Close Menu

Proteome Sciences

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Proteome Sciences today said that it will be performing biomarker analysis for a new European research initiative to study hypothermia as a treatment after stroke.

Proteome Sciences announced this week positive results from research testing several compounds as inhibitors against the candidate Alzheimer's drug target casein kinase 1 delta, or CK1δ.

Ohio State University of Columbus, Ohio, has received US Patent No. 8,075,854, "Microfluidic chips for rapid multiplex ELISA. "The patent claims a microfluidic chip that consists of a substrate and a channel or multiple channels in the substrate.

Proteome Sciences said this week it has signed an agreement with Siena Biotech making it the preferred supplier of protein and peptide biomarker services for Siena's drug development research.

The firm, Proteomedix Frontiers, has developed SRM-MS assays for more than 400 proteins that could be important to drug development efforts. It plans to offer them to pharma researchers both as kits and through agreements with contract research organizations.

Pages

A new analysis finds some cancers receive more nonprofit dollars than others.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.